Nephrogenic fibrosing dermopathy differential diagnosis

Nephrogenic fibrosing dermopathy Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Nephrogenic fibrosing dermopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Nephrogenic fibrosing dermopathy differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Nephrogenic fibrosing dermopathy differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Nephrogenic fibrosing dermopathy differential diagnosis
CDC on Nephrogenic fibrosing dermopathy differential diagnosis
Nephrogenic fibrosing dermopathy differential diagnosis in the news
Blogs on Nephrogenic fibrosing dermopathy differential diagnosis
Directions to Hospitals Treating Nephrogenic fibrosing dermopathy
Risk calculators and risk factors for Nephrogenic fibrosing dermopathy differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]

Differentiating Nephrogenic fibrosing dermopathy from other Diseases

Nephrogenic fibrosing dermopathy must be differentiated from other diseases that cause skin thickening and edema such as scleredema, scleromyxedema, eosinophilic fasciitis, scleroderma, drug induced scleroderma, scleroderma overlap syndromes, diabetic cheiroarthropathy, myxedema and Chronic graft-versus-host disease.